Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Erritzoe

Showing results (21-30 of 143) with videos related to

Pageof 15
Sort By:
Frontiers in Psychology|December 13, 2021
Examining Psychedelic-Induced Changes in Social Functioning and Connectedness in a Naturalistic Online Sample Using the Five-Factor Model of PersonalityBrandon Weiss, Victoria Nygart, Lis Marie Pommerencke, et al.
Scientific Reports|February 7, 2024
Effects of DMT on mental health outcomes in healthy volunteersChristopher Timmermann, Richard J Zeifman, David Erritzoe, et al.
Molecular Psychiatry|September 27, 2023
Neuroimaging in psychedelic drug development: past, present, and futureMatthew B Wall, Rebecca Harding, Rayyan Zafar, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 24, 2025
The effects of psilocybin therapy versus escitalopram on cognitive bias: A secondary analysis of a randomized controlled trialJessica Henry, Bruna Giribaldi, David J Nutt, et al.
Journal of Psychopharmacology (Oxford, England)|March 16, 2024
Psychiatric risks for worsened mental health after psychedelic useAlessia Marrocu, Hannes Kettner, Brandon Weiss, et al.
Biological Psychiatry|February 10, 2023
Reply to: No Clear Evidence of Reduced Brain Serotonin Release Capacity in Patients With DepressionEugenii A Rabiner, Claudio Agnorelli, Oliver Howes, et al.
Journal of Magnetic Resonance Imaging : JMRI|December 16, 2011
Fluid and white matter suppression with the MP2RAGE sequenceMark Tanner, Giulio Gambarota, Tobias Kober, et al.
Journal of Psychopharmacology (Oxford, England)|January 28, 2024
Interactions between classic psychedelics and serotonergic antidepressants: Effects on the acute psychedelic subjective experience, well-being and depressive symptoms from a prospective survey studyJessica Barbut Siva, Tommaso Barba, Hannes Kettner, et al.
Journal of Psychopharmacology (Oxford, England)|March 1, 2019
Recreational use of psychedelics is associated with elevated personality trait openness: Exploration of associations with brain serotonin markersDavid Erritzoe, James Smith, Patrick M Fisher, et al.
Journal of Psychopharmacology (Oxford, England)|February 16, 2018
Psychedelics and the essential importance of contextRobin L Carhart-Harris, Leor Roseman, Eline Haijen, et al.
Pageof 15

Showing results (21-30 of 143) with videos related to

Sort By:
Pageof 15
Frontiers in Psychology|December 13, 2021
Examining Psychedelic-Induced Changes in Social Functioning and Connectedness in a Naturalistic Online Sample Using the Five-Factor Model of PersonalityBrandon Weiss, Victoria Nygart, Lis Marie Pommerencke, et al.
Scientific Reports|February 7, 2024
Effects of DMT on mental health outcomes in healthy volunteersChristopher Timmermann, Richard J Zeifman, David Erritzoe, et al.
Molecular Psychiatry|September 27, 2023
Neuroimaging in psychedelic drug development: past, present, and futureMatthew B Wall, Rebecca Harding, Rayyan Zafar, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 24, 2025
The effects of psilocybin therapy versus escitalopram on cognitive bias: A secondary analysis of a randomized controlled trialJessica Henry, Bruna Giribaldi, David J Nutt, et al.
Journal of Psychopharmacology (Oxford, England)|March 16, 2024
Psychiatric risks for worsened mental health after psychedelic useAlessia Marrocu, Hannes Kettner, Brandon Weiss, et al.
Biological Psychiatry|February 10, 2023
Reply to: No Clear Evidence of Reduced Brain Serotonin Release Capacity in Patients With DepressionEugenii A Rabiner, Claudio Agnorelli, Oliver Howes, et al.
Journal of Magnetic Resonance Imaging : JMRI|December 16, 2011
Fluid and white matter suppression with the MP2RAGE sequenceMark Tanner, Giulio Gambarota, Tobias Kober, et al.
Journal of Psychopharmacology (Oxford, England)|January 28, 2024
Interactions between classic psychedelics and serotonergic antidepressants: Effects on the acute psychedelic subjective experience, well-being and depressive symptoms from a prospective survey studyJessica Barbut Siva, Tommaso Barba, Hannes Kettner, et al.
Journal of Psychopharmacology (Oxford, England)|March 1, 2019
Recreational use of psychedelics is associated with elevated personality trait openness: Exploration of associations with brain serotonin markersDavid Erritzoe, James Smith, Patrick M Fisher, et al.
Journal of Psychopharmacology (Oxford, England)|February 16, 2018
Psychedelics and the essential importance of contextRobin L Carhart-Harris, Leor Roseman, Eline Haijen, et al.
Pageof 15